Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2022.2160703
Abstract: ABSTRACT Introduction Glioblastoma Multiforme (GBM) is one of the fatal cancers of the Central Nervous System (CNS). A variety of reasons exist for why previous immunotherapy strategies, especially Immune Checkpoint Blockers (ICBs), did not work… read more here.
Keywords: ctla; preclinical evidence; glioblastoma preclinical; ctla axes ... See more keywords